Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
Prostate cancer (PC) is a commonly diagnosed malignancy in men and is associated with high mortality rates. Current treatments for PC include surgery, chemotherapy, and radiation therapy. However, recent advances in targeted delivery systems have yielded promising new approaches to PC treatment. As...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Molecular & Cellular Oncology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/23723556.2022.2136476 |
| _version_ | 1797677102079672320 |
|---|---|
| author | Amir Yarahmadi Romoye Sohan Brenna McAllister Leslie A. Caromile |
| author_facet | Amir Yarahmadi Romoye Sohan Brenna McAllister Leslie A. Caromile |
| author_sort | Amir Yarahmadi |
| collection | DOAJ |
| description | Prostate cancer (PC) is a commonly diagnosed malignancy in men and is associated with high mortality rates. Current treatments for PC include surgery, chemotherapy, and radiation therapy. However, recent advances in targeted delivery systems have yielded promising new approaches to PC treatment. As PC epithelial cells express high levels of prostate-specific membrane antigen (PSMA) on the cell surface, new drug conjugates focused on PSMA targeting have been developed. microRNAs (miRNAs) are small noncoding RNAs that regulate posttranscriptional gene expression in cells and show excellent possibilities for use in developing new therapeutics for PC. PSMA-targeted therapies based on a miRNA payload and that selectively target PC cells enhances therapeutic efficacy without eliciting damage to normal surrounding tissue. This review discusses the rationale for utilizing miRNAs to target PSMA, revealing their potential in therapeutic approaches to PC treatment. Different delivery systems for miRNAs and challenges to miRNA therapy are also explored. |
| first_indexed | 2024-03-11T22:40:09Z |
| format | Article |
| id | doaj.art-b9223a6d0264428aa32527de7bb42c37 |
| institution | Directory Open Access Journal |
| issn | 2372-3556 |
| language | English |
| last_indexed | 2024-03-11T22:40:09Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Molecular & Cellular Oncology |
| spelling | doaj.art-b9223a6d0264428aa32527de7bb42c372023-09-22T09:19:44ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562022-12-019110.1080/23723556.2022.21364762136476Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active targetAmir Yarahmadi0Romoye Sohan1Brenna McAllister2Leslie A. Caromile3Mashhad University of Medical SciencesUniversity of Connecticut Health CenterUniversity of Connecticut Health CenterUniversity of Connecticut Health CenterProstate cancer (PC) is a commonly diagnosed malignancy in men and is associated with high mortality rates. Current treatments for PC include surgery, chemotherapy, and radiation therapy. However, recent advances in targeted delivery systems have yielded promising new approaches to PC treatment. As PC epithelial cells express high levels of prostate-specific membrane antigen (PSMA) on the cell surface, new drug conjugates focused on PSMA targeting have been developed. microRNAs (miRNAs) are small noncoding RNAs that regulate posttranscriptional gene expression in cells and show excellent possibilities for use in developing new therapeutics for PC. PSMA-targeted therapies based on a miRNA payload and that selectively target PC cells enhances therapeutic efficacy without eliciting damage to normal surrounding tissue. This review discusses the rationale for utilizing miRNAs to target PSMA, revealing their potential in therapeutic approaches to PC treatment. Different delivery systems for miRNAs and challenges to miRNA therapy are also explored.http://dx.doi.org/10.1080/23723556.2022.2136476psmaprostate cancermirnatherapytargeted delivery |
| spellingShingle | Amir Yarahmadi Romoye Sohan Brenna McAllister Leslie A. Caromile Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target Molecular & Cellular Oncology psma prostate cancer mirna therapy targeted delivery |
| title | Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target |
| title_full | Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target |
| title_fullStr | Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target |
| title_full_unstemmed | Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target |
| title_short | Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target |
| title_sort | therapeutic potential of targeting mirnas to prostate cancer tumors using psma as an active target |
| topic | psma prostate cancer mirna therapy targeted delivery |
| url | http://dx.doi.org/10.1080/23723556.2022.2136476 |
| work_keys_str_mv | AT amiryarahmadi therapeuticpotentialoftargetingmirnastoprostatecancertumorsusingpsmaasanactivetarget AT romoyesohan therapeuticpotentialoftargetingmirnastoprostatecancertumorsusingpsmaasanactivetarget AT brennamcallister therapeuticpotentialoftargetingmirnastoprostatecancertumorsusingpsmaasanactivetarget AT leslieacaromile therapeuticpotentialoftargetingmirnastoprostatecancertumorsusingpsmaasanactivetarget |